Concepts (98)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carcinoma, Squamous Cell | 3 | 2019 | 155 | 1.570 |
Why?
|
| Ultrasonography, Interventional | 3 | 2018 | 38 | 1.260 |
Why?
|
| Lymphatic Metastasis | 2 | 2019 | 119 | 1.230 |
Why?
|
| Head and Neck Neoplasms | 2 | 2019 | 84 | 1.150 |
Why?
|
| Craniocerebral Trauma | 2 | 2018 | 26 | 0.840 |
Why?
|
| Endocarditis | 1 | 2022 | 16 | 0.770 |
Why?
|
| Round Window, Ear | 1 | 2019 | 10 | 0.670 |
Why?
|
| Temporal Bone | 1 | 2019 | 29 | 0.670 |
Why?
|
| Thyroid Neoplasms | 1 | 2019 | 37 | 0.620 |
Why?
|
| Image-Guided Biopsy | 4 | 2019 | 20 | 0.590 |
Why?
|
| Ultrasonography | 1 | 2019 | 229 | 0.590 |
Why?
|
| Child Abuse | 1 | 2018 | 89 | 0.580 |
Why?
|
| Mouth Neoplasms | 1 | 2016 | 55 | 0.490 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 811 | 0.460 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2013 | 2 | 0.440 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2013 | 22 | 0.440 |
Why?
|
| Brain | 2 | 2022 | 710 | 0.430 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2013 | 466 | 0.360 |
Why?
|
| Humans | 15 | 2022 | 27119 | 0.320 |
Why?
|
| Biopsy, Large-Core Needle | 2 | 2018 | 7 | 0.300 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2018 | 24 | 0.300 |
Why?
|
| Meningioma | 2 | 2019 | 79 | 0.290 |
Why?
|
| Oral Surgical Procedures | 1 | 2005 | 6 | 0.240 |
Why?
|
| Guidelines as Topic | 1 | 2004 | 44 | 0.220 |
Why?
|
| Bicycling | 1 | 2004 | 40 | 0.220 |
Why?
|
| Retrospective Studies | 4 | 2018 | 2454 | 0.220 |
Why?
|
| Clinical Competence | 1 | 2005 | 216 | 0.220 |
Why?
|
| Male | 7 | 2019 | 13022 | 0.200 |
Why?
|
| Health Promotion | 1 | 2004 | 169 | 0.200 |
Why?
|
| Neuroimaging | 1 | 2022 | 86 | 0.190 |
Why?
|
| Female | 7 | 2019 | 14635 | 0.190 |
Why?
|
| Aged | 4 | 2019 | 5222 | 0.180 |
Why?
|
| Middle Aged | 5 | 2019 | 6900 | 0.180 |
Why?
|
| Sensitivity and Specificity | 2 | 2018 | 508 | 0.170 |
Why?
|
| Orientation | 1 | 2019 | 15 | 0.170 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 31 | 0.170 |
Why?
|
| Radiotherapy, Intensity-Modulated | 1 | 2019 | 35 | 0.160 |
Why?
|
| Shaken Baby Syndrome | 1 | 2018 | 5 | 0.160 |
Why?
|
| Hematoma, Subdural | 1 | 2018 | 4 | 0.160 |
Why?
|
| Skull Fractures | 1 | 2018 | 18 | 0.160 |
Why?
|
| Lymph Nodes | 1 | 2018 | 97 | 0.150 |
Why?
|
| Diagnosis, Differential | 1 | 2019 | 367 | 0.140 |
Why?
|
| Endolymphatic Sac | 1 | 1997 | 1 | 0.140 |
Why?
|
| Meniere Disease | 1 | 1997 | 2 | 0.140 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 750 | 0.140 |
Why?
|
| Thrombosis | 1 | 2018 | 147 | 0.140 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2017 | 22 | 0.140 |
Why?
|
| Child | 2 | 2018 | 2160 | 0.140 |
Why?
|
| Meningeal Neoplasms | 1 | 2017 | 73 | 0.140 |
Why?
|
| Tongue | 1 | 2016 | 7 | 0.130 |
Why?
|
| Tongue Neoplasms | 1 | 2016 | 6 | 0.130 |
Why?
|
| Radiology, Interventional | 1 | 2016 | 6 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 47 | 0.130 |
Why?
|
| Mouth | 1 | 2016 | 31 | 0.130 |
Why?
|
| Infant | 1 | 2018 | 966 | 0.120 |
Why?
|
| Aged, 80 and over | 1 | 2018 | 1940 | 0.110 |
Why?
|
| Autoantibodies | 1 | 1997 | 472 | 0.110 |
Why?
|
| Syndrome | 1 | 2013 | 78 | 0.110 |
Why?
|
| Lateral Ventricles | 1 | 2013 | 8 | 0.110 |
Why?
|
| Encephalitis, Herpes Simplex | 1 | 2013 | 6 | 0.110 |
Why?
|
| Internship and Residency | 1 | 2016 | 228 | 0.100 |
Why?
|
| Interferon Type I | 1 | 2013 | 55 | 0.100 |
Why?
|
| Microglia | 1 | 2013 | 58 | 0.100 |
Why?
|
| Young Adult | 1 | 2018 | 2626 | 0.090 |
Why?
|
| Adolescent | 1 | 2018 | 2988 | 0.090 |
Why?
|
| Adult | 1 | 2018 | 7492 | 0.070 |
Why?
|
| Signal Transduction | 1 | 2013 | 1379 | 0.070 |
Why?
|
| Head Protective Devices | 1 | 2004 | 6 | 0.060 |
Why?
|
| Computer Simulation | 1 | 2005 | 221 | 0.060 |
Why?
|
| Research Design | 1 | 2004 | 174 | 0.050 |
Why?
|
| Models, Biological | 1 | 2005 | 448 | 0.050 |
Why?
|
| Oklahoma | 1 | 2004 | 978 | 0.040 |
Why?
|
| Safety | 1 | 2019 | 32 | 0.040 |
Why?
|
| Neoplasm Grading | 1 | 2019 | 104 | 0.040 |
Why?
|
| Risk | 1 | 2019 | 133 | 0.040 |
Why?
|
| Survival Analysis | 1 | 2019 | 278 | 0.040 |
Why?
|
| Recurrence | 1 | 2019 | 316 | 0.040 |
Why?
|
| Survival Rate | 1 | 2017 | 411 | 0.030 |
Why?
|
| Animals | 2 | 2013 | 10080 | 0.030 |
Why?
|
| Microscopy, Fluorescence | 1 | 1997 | 163 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 1997 | 455 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2017 | 595 | 0.030 |
Why?
|
| Curriculum | 1 | 2016 | 271 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2017 | 1219 | 0.030 |
Why?
|
| Radiation Chimera | 1 | 2013 | 5 | 0.030 |
Why?
|
| Leukemia Inhibitory Factor Receptor alpha Subunit | 1 | 2013 | 3 | 0.030 |
Why?
|
| Herpesvirus 1, Human | 1 | 2013 | 24 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2017 | 605 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2013 | 675 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2017 | 2283 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2013 | 794 | 0.020 |
Why?
|
| United States | 1 | 2016 | 2060 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2013 | 655 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 1268 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2013 | 1496 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2013 | 1405 | 0.020 |
Why?
|
| Mice | 1 | 2013 | 4473 | 0.010 |
Why?
|